Aurore Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Aurore Pharmaceuticals Private Limited

Aurore Pharmaceuticals Private Limited, a active private limited company, was established on 15 May 2017 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2017PTC117032. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹42.11 Cr.

Formerly known as Sphery Lifesciences Private Limited. It upholds a compliant status. Employing 451 professional, Its leadership includes Sareddy Reddy Ravisankara (Nominee Director), Sailesh Jhawar Kumar (Director). Past directors included Vamsilatha Thulasi, Dayakar Reddy Mallu, Allada Trisha. It holds ₹320.00 Cr open charges and ₹2.50 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot # 68,69, 2Nd Floor, Jubilee Heights Beside Shilparamam, Madhapur, Hyderabad, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2017PTC117032

  • Registration Number

    117032

  • Incorporation Date

    15 May 2017

  • Authorized Capital

    ₹50.00 Cr

  • Paid-Up Capital

    ₹42.11 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 50.00 Cr
  • Paid Up Capital ₹ 42.11 Cr
  • Company Age 8 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 320.00 Cr
  • Satisfied Charges ₹ 2.50 Cr
  • Revenue Growth **** 133.38%
  • Profit Growth **** -71.66%
  • Ebitda **** -131.92%
  • Net Worth -89.37%
  • Total Assets **** 15.10%
Company report

Aurore Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aurore Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aurore Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sareddy Reddy Ravisankara Nominee Director 06 Dec 2022 Current
Sailesh Jhawar Kumar Director 18 Sep 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 04 Oct 2024 Past
Pramod Abcsdd Additional Director 31 Dec 2018 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 04 Jan 2023 Past
Pramod Abcsdd Additional Director 31 Dec 2021 Past
Pramod Abcsdd Director 15 Feb 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aurore Pharmaceuticals.

Aurore Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 133.38% increase. The company also saw a substantial fall in profitability, with a 71.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.37%.

Aurore Pharmaceuticals revenue growth over time
Aurore Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 133.38%
*******
*******
*******
*******
Revenue from Operations
*******
 133.48%
*******
*******
*******
*******
Total Assets
*******
 15.10%
*******
*******
*******
*******
Profit or Loss
*******
 -71.66%
*******
*******
*******
*******
Net Worth
*******
 -89.37%
*******
*******
*******
*******
EBITDA
*******
 -131.92%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aurore Pharmaceuticals?

In 2022, Aurore Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,200,000,000.00

Satisfied Charges

₹25,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 300.00 Cr
  • Yes Bank Limited : 20.00 Cr
Latest Charge Details
Date Lender Amount Status
26 Sep 2024 Others ₹300.00 Cr Open
29 May 2018 Yes Bank Limited ₹20.00 Cr Open
15 Jun 2018 Axis Bank Limited ₹2.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aurore Pharmaceuticals?

Aurore Pharmaceuticals has a workforce of 451 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aurore Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurore Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aurore Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Aurore Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge registered on 15 Jun 2018 via Charge ID 100198200 with Axis Bank Limited was fully satisfied on 03 Jun 2025. was completed.

  • Balance Sheet

    Aurore Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Pooja Toshniwal was appointed as a Company Secretary was appointed as a Company Secretary on 06 Jan 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 300.00 Cr registered on 26 Sep 2024 with Charge ID 101017337 was modified on 19 Nov 2024. was documented.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 2.50 Cr registered on 15 Jun 2018 with Charge ID 100198200 was modified on 30 Oct 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aurore Pharmaceuticals Private Limited?

The CIN of Aurore Pharmaceuticals Private Limited is U24239TG2017PTC117032.

Where is Aurore Pharmaceuticals Private Limited headquartered?

Aurore Pharmaceuticals Private Limited is headquartered at Plot # 68,69, 2Nd Floor, Jubilee Heights Beside Shilparamam, Madhapur, Hyderabad, Telangana, 500081.

When was Aurore Pharmaceuticals Private Limited incorporated?

Aurore Pharmaceuticals Private Limited was incorporated on 15 May 2017.

Who are the current directors of Aurore Pharmaceuticals Private Limited?

The current directors of Aurore Pharmaceuticals Private Limited are

What is the primary industry of Aurore Pharmaceuticals Private Limited?

The primary industry of Aurore Pharmaceuticals Private Limited is Manufacturing.

Is Aurore Pharmaceuticals Private Limited a listed company?

Aurore Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Aurore Pharmaceuticals Private Limited?

The authorized capital of Aurore Pharmaceuticals Private Limited is ₹50.00 Cr, and the paid-up capital is ₹42.11 Cr.

What is the compliance status of Aurore Pharmaceuticals Private Limited?

The compliance status of Aurore Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available